Angina gene therapy company XyloCor raises $17M series A round

Angina gene therapy company XyloCor raises $17M series A round

Source: 
BioCentury
snippet: 

Gene therapy company XyloCor Therapeutics Inc. (Philadelphia, Pa.) raised $17 million in a series A round led by Sofinnova Ventures and Life Science Partners.